SCREEN SPE USA, LLC

SCREEN Holdings Co., Ltd. is one of world’s largest Semiconductor and Electronics company with numerous market leading products. In addition to manufacture and sale of semiconductor production and measurement equipment, SCREEN is engaged in providing precision technology solutions for manufacturing flat panel displays (FPDs), printed circuit boards (PCBs), graphic arts equipment, etc. In keeping with the SCREEN’s core values of continuing to search for better ways to improve human lives and make a sustainable contribution to society, SCREEN founded its Life Science branch to help biomedical research community in their quest to discover more effective therapeutic options for patients. SCREEN delivers a comprehensive portfolio of imaging devices and software solutions to support preclinical drug discovery and development studies. SCREEN’s translational imaging and image analysis solutions enables the researchers to image phenotypic changes in cells grown in either 2D or 3D culture settings, within a matter of minutes which could otherwise take weeks to perform. Building on a history that stretches back to our foundation in 1868, Dainippon Screen Mfg. Co., Ltd. made a new start as SCREEN Holdings Co., Ltd. in October 2014. Over the past 148 years, our commitment to continuously meeting evolving needs has enabled us to grow into a global enterprise employing nearly 10,000 people worldwide.

SCREEN has commercialized a high-speed 3D cell culture scanner and cell morphology analysis system that both use our proprietary image processing technologies. The devices are able to perform high-speed measurement and analysis of the multiplication and morphological changes in cells without using a test reagent. They are already accelerating research related to the development of cancer drugs and also regenerative medicine.